Published in Brain Res Mol Brain Res on October 22, 2004
Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A (2013) 1.94
Microarrays. Dev Sci (2007) 0.87
Natural variation in maternal care and cross-tissue patterns of oxytocin receptor gene methylation in rats. Horm Behav (2015) 0.83
Assessing individual differences in genome-wide gene expression in human whole blood: reliability over four hours and stability over 10 months. Twin Res Hum Genet (2009) 0.83
Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology (2011) 0.83
Genome-wide methylation profiling demonstrates hypermethylation in maternal leukocyte DNA in preeclamptic compared to normotensive pregnancies. Hypertens Pregnancy (2013) 0.81
Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder. World J Biol Psychiatry (2013) 0.79
Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). BMC Med Genomics (2017) 0.75
RNA-Seq analysis of seasonal and individual variation in blood transcriptomes of healthy managed bottlenose dolphins. BMC Genomics (2016) 0.75
The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder. Mol Psychiatry (2017) 0.75
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis (2013) 6.04
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis (2002) 3.42
Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 2.73
The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc (2004) 2.47
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis (2009) 2.43
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14
A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun (2010) 1.95
Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94
Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol (2008) 1.93
A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003) 1.80
The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med (2005) 1.78
Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol (2006) 1.75
Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol (2005) 1.67
Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn (2011) 1.64
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty. Cancer (2013) 1.64
Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol (2007) 1.60
Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust N Z J Psychiatry (2009) 1.57
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis (2003) 1.39
Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry (2006) 1.31
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 1.26
Post-licensure monitoring of HPV vaccine in the United States. Vaccine (2010) 1.24
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers (2002) 1.20
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability. Theor Biol Med Model (2007) 1.18
A real-time PCR assay for HPV52 detection and viral load quantification. Clin Lab (2012) 1.18
DNA and RNA references for qRT-PCR assays in exfoliated cervical cells. J Mol Diagn (2006) 1.15
Primary and secondary prevention of cervical cancer--opportunities and challenges. J Natl Cancer Inst (2009) 1.13
Human papillomavirus and molecular considerations for cancer risk. Cancer (2008) 1.12
Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis (2012) 1.12
Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? J Psychosom Res (2004) 1.12
Population impact of HPV vaccines: summary of early evidence. J Adolesc Health (2013) 1.12
Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact? J Infect Dis (2011) 1.11
Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome. J Transl Med (2003) 1.10
Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics (2008) 1.09
Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology (2008) 1.08
Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med (2008) 1.06
Seroprevalence of human papillomavirus type 16 in children. J Infect Dis (2005) 1.06
Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach. PLoS One (2012) 1.06
Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurol (2006) 1.05
CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep (2014) 1.05
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics (2006) 1.05
Type-specific reproducibility of the Roche linear array HPV genotyping test. J Clin Virol (2008) 1.04
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis (2014) 1.04
Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Impaired immune function in Gulf War Illness. BMC Med Genomics (2009) 1.03
Gene expression correlates of unexplained fatigue. Pharmacogenomics (2006) 1.03
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. Vaccine (2012) 1.03
Evaluation of the rapid BioStar optical immunoassay for detection of Chlamydia trachomatis in adolescent women. J Clin Microbiol (2008) 1.03
Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Methods (2006) 1.02
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis (2013) 1.02
National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2003) 1.02
Performance of commercial reverse line blot assays for human papillomavirus genotyping. J Clin Microbiol (2012) 1.01
Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behav Brain Funct (2008) 1.00
Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol (2005) 1.00
Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis (2013) 0.99
Regional distribution of fatiguing illnesses in the United States: a pilot study. Popul Health Metr (2004) 0.98
Minimum data elements for research reports on CFS. Brain Behav Immun (2012) 0.96
Impact of RNA extraction from limited samples on microarray results. Biotechniques (2003) 0.95
Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. J Low Genit Tract Dis (2014) 0.94
Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association. Neuromolecular Med (2010) 0.94
Coping styles in people with chronic fatigue syndrome identified from the general population of Wichita, KS. J Psychosom Res (2006) 0.94
Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening. J Womens Health (Larchmt) (2013) 0.93
Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med (Berl) (2004) 0.93
Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol (2005) 0.92
Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009. Cancer Causes Control (2014) 0.92
A method for improving SELDI-TOF mass spectrometry data quality. Proteome Sci (2007) 0.92
Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery. BMC Genomics (2005) 0.92
Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstet Gynecol (2014) 0.91
Effect of storage temperatures on the stability of cytokines in cervical mucous. Cytokine (2007) 0.91
Assessment of normal variability in peripheral blood gene expression. Dis Markers (2002) 0.91
Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome. Mol Med (2008) 0.91
Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction. PLoS Comput Biol (2009) 0.90
Impact of acute psychosocial stress on peripheral blood gene expression pathways in healthy men. Biol Psychol (2009) 0.89
The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions. Cancer Causes Control (2011) 0.89
Characterization of the Human Cervical Mucous Proteome. Clin Proteomics (2010) 0.88
Bioelectronic DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogens. BMC Infect Dis (2003) 0.88
Optimization of SELDI-TOF protein profiling for analysis of cervical mucous. J Proteomics (2008) 0.88